Paloma Partners Management Co - CELLULAR BIOMEDICINE GROUP I ownership

CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 24 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Paloma Partners Management Co ownership history of CELLULAR BIOMEDICINE GROUP I
ValueSharesWeighting
Q3 2020$362,000
-7.2%
19,740
-55.7%
0.01%
+80.0%
Q2 2017$390,00044,5250.01%
Other shareholders
CELLULAR BIOMEDICINE GROUP I shareholders Q2 2017
NameSharesValueWeighting ↓
S. MUOIO & CO. LLC 52,468$964,0001.05%
Olympiad Research LP 54,795$1,007,0000.58%
Alpine Global Management, LLC 119,902$2,204,0000.45%
GABELLI & Co INVESTMENT ADVISERS, INC. 65,922$1,212,0000.19%
First Trust Capital Management L.P. 32,688$601,0000.17%
GLAZER CAPITAL, LLC 232,103$4,266,0000.15%
Walleye Capital LLC 105,000$1,930,0000.13%
Yakira Capital Management, Inc. 17,588$323,0000.08%
Dynamic Technology Lab Private Ltd 17,929$330,0000.05%
EQUITEC PROPRIETARY MARKETS, LLC 10,600$195,0000.05%
View complete list of CELLULAR BIOMEDICINE GROUP I shareholders